Group One Trading’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Group One Trading's IMNM Position: Q1 2026 in Review
Group One Trading sold out of Immunome (IMNM) in Q1 2026, closing a stake of 22,999 shares — an estimated $512K sold.
Group One Trading first reported a position in IMNM in Q2 2022 and held it in 10 quarters. The position peaked at $494K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Group One Trading reported no remaining Immunome position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 22,999 Immunome shares in Q1 2026, an estimated $512K.
- Group One Trading first reported a position in Immunome in Q2 2022 and held it in 10 quarters.
- Group One Trading's Immunome position peaked at $494K in Q4 2025.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.